Vicente Larraga

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.

A. Alonso, V. Larraga, J. Castillo, 2008, Vaccine.

Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum.

G. González-Aseguinolaza, S. Taladriz, A. Marquet, 2001, European journal of biochemistry.